Insider Transactions in Q2 2024 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Spencer R Berthelsen Director |
SELL
Open market or private sale
|
Direct |
16,000
-9.8%
|
$640,000
$40.29 P/Share
|
|
Jun 17
2024
|
Spencer R Berthelsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+8.93%
|
$560,000
$35.53 P/Share
|
|
May 09
2024
|
Joseph H Wender Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
16,000
+11.11%
|
$560,000
$35.53 P/Share
|
|
May 03
2024
|
Joseph Klein Iii Director |
SELL
Open market or private sale
|
Indirect |
6,000
-41.42%
|
$252,000
$42.76 P/Share
|
|
Apr 16
2024
|
Brian Birchler EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct |
905
-1.92%
|
$37,105
$41.66 P/Share
|
|
Apr 16
2024
|
Joseph Baroldi EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,006
-16.95%
|
$164,246
$41.6 P/Share
|
|
Apr 15
2024
|
Brian Birchler EVP, Corp and Development Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+3.83%
|
-
|
|
Apr 15
2024
|
Joseph Baroldi EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,838
+31.44%
|
-
|